Immix Biopharma Inc (IMMX)

Finanzdaten der Immix Biopharma Inc-Aktie (IMMX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	15.30%12.46	10.80	10.89	7.66	6.72
Research and Development	10.82%5.33	5.98	5.73	4.58	3.97
Operating Income/Loss	15.30%-12.46	-10.80	-10.89	-7.66	-6.72
Nonoperating Income/Loss	27.40%0.91	0.72	0.22	0.08	0.10
Income/Loss From Continuing Operations Before Tax	14.43%-11.54	-10.09	-10.68	-7.58	-6.61
Income Tax Expense/Benefit	0.01	-	0.01	0.01	0.01
	14.43%-11.56	-10.10	-10.69	-7.59	-6.62
Attributable To Parent	14.58%-11.56	-10.09	-10.69	-7.59	-6.62
Basic Average Shares	15.17%63.77	55.37	-	31.93	29.98
Diluted Average Shares	15.17%63.77	55.37	-	31.93	29.98
Basic Earnings Per Share	-0.18	-0.18	-	-0.24	-0.22
Diluted Earnings Per Share	-0.18	-0.18	-	-0.24	-0.22